99% Purity High Quality 5mg 10mg 15mg In Stock Safe Shipping Tirzepatide

Product Description:

Tirzepatide powder is the active pharmaceutical ingredient of Tirzepatide, a novel synthetic peptide designed for the treatment of type 2 diabetes and potentially for obesity management. As a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, Tirzepatide enhances the body’s natural insulin response, decreases glucagon secretion, and slows gastric emptying. These actions work synergistically to improve glycemic control and facilitate weight loss in patients. The powder form is primarily used in pharmaceutical manufacturing, where it undergoes precise formulation into injectable medications for clinical application. Tirzepatide is administered through subcutaneous injections, with dosages typically starting low and gradually increased based on patient response and tolerance. The introduction of Tirzepatide marks a significant advancement in diabetes treatment, offering patients a new mechanism of action that not only targets blood sugar levels but also addresses weight management. As research continues, Tirzepatide shows promise for broader applications in metabolic health, potentially transforming the therapeutic landscape for individuals with type 2 diabetes.

Technical Parameters:

Dosage:

The dosage of Tirzepatide for treating type 2 diabetes, typically follows a gradual titration to minimize side effects and optimize effectiveness. It is administered via subcutaneous injection once weekly.
 
Here’s a general dosing schedule:
 
1. Starting dose: 2.5 mg once a week for the first 4 weeks. This low dose helps the body adjust to the medication.
2. Dose escalation:
After 4 weeks at 2.5 mg, the dose is increased to 5 mg once weekly.
If further blood sugar control is needed, the dose may be increased in 2.5 mg increments every 4 weeks, up to a maximum dose of 15 mg per week.
 
Titration schedule:
Week 1–4: 2.5 mg weekly
Week 5–8: 5 mg weekly
After 8 weeks: Based on effectiveness and tolerance, the dose may be increased to 7.5 mg, 10 mg, 12.5 mg, or 15 mg.
The dosage is tailored to the individual patient’s needs and response to the medication. Higher doses may offer additional benefits for glucose control and weight loss, but they also increase the likelihood of gastrointestinal side effects, such as nausea or diarrhea.
 
Patients should follow the dosage prescribed by their healthcare provider to ensure safety and efficacy.
 

Function:

1. Dual Agonism:

Tirzepatide acts as a dual agonist for the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. This mechanism allows it to exert effects on glucose metabolism through multiple pathways, enhancing its therapeutic efficacy.

2. Insulin Secretion:

By stimulating GLP-1 and GIP receptors, Tirzepatide promotes increased insulin secretion from the pancreas in response to elevated blood glucose levels. This helps lower blood sugar, especially after meals.

3. Glucagon Suppression:

Tirzepatide reduces glucagon secretion, a hormone that raises blood sugar levels. By suppressing glucagon, it helps maintain lower blood glucose levels and prevents hyperglycemia.

4. Slowed Gastric Emptying:

The medication slows gastric emptying, leading to a more gradual release of glucose into the bloodstream. This helps improve postprandial blood sugar control and enhances the feeling of fullness after meals.

5. Weight Loss:

Tirzepatide has been shown to promote significant weight loss by reducing appetite and increasing satiety. This is particularly beneficial for individuals with type 2 diabetes who are overweight or obese, as weight management is crucial for improving metabolic health.

Packing and Shipping: